GENEVA, Feb. 2 -- UCB BIOPHARMA SRL (Allee de la Recherche 601070 Brussels) filed a patent application (PCT/EP2025/071119) for "DIBENZOAZEPINONE BASED COMPOUNDS AS THERAPEUTIC AGENTS FOR CANCER TREATMENT" on Jul 23, 2025. With publication no. WO/2026/022197, the details related to the patent application was published on Jan 29, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): MANTEAU, Baptiste (c/o IPDUCB Biopharma SRLAllee de la Recherche 601070 Brussels), PROVINS, Laurent (c/o IPDUCB Biopharma SRLAllee de la Recherche 601070 Brussels)
Abstract: The present invention relates to a compound o...